Ms. Benjamin formerly led social impact efforts at Eli Lilly and Co. and helmed its charitable arm as president. In 2020, she chartered the Lilly Foundation’s initiatives to combat COVID-19 and racial inequity.
“Our board of directors is excited to introduce a leader of Tiffany’s caliber to help guide the strategic direction of the Humana Foundation while continuing a legacy of supporting organizations that do indispensable work in our communities,” said Bruce Broussard, president and CEO of Humana and Humana Foundation board of directors chair. “She brings a strong sense of purpose and deep strategic perspective to engaging our communities and accelerating best health outcomes for all.”
Ms. Benjamin begins her term Jan. 3 where she takes over for interim CEO Caraline Coats, who assumed the role July 1. Humana has since tapped Ms. Coats to lead its South Florida Medicare market.
